Painless liver scan could spot hidden damage in heavy drinkers with extra weight
NCT ID NCT06924281
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding a quick, painless liver scan (Fibroscan®) to standard screening questions could better identify people at risk for liver disease caused by both alcohol and excess weight. Fourteen English- or Spanish-speaking adults from underserved communities took part. The goal was to see if this approach was practical and acceptable, not to provide a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEATOTIC LIVER DISEASE OF MIXED ORIGIN (METALD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinica Esperanza Hope Clinic
Providence, Rhode Island, 02909, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.